LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | SNS-032 | 3.33 | uM | LJP6 | 3 | H14 | 72 | hr | 1311 | 774 | 4973 | 0.1556 | -0.2399 |
MDA-MB-231 | SNS-032 | 10 | uM | LJP6 | 1 | H13 | 72 | hr | 1311 | 775 | 4870 | 0.1591 | -0.2428 |
MDA-MB-231 | SNS-032 | 10 | uM | LJP6 | 2 | H13 | 72 | hr | 1311 | 805 | 4961 | 0.1622 | -0.2246 |
MDA-MB-231 | SNS-032 | 10 | uM | LJP6 | 3 | H13 | 72 | hr | 1311 | 875 | 4973 | 0.1759 | -0.1899 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 1311 | 4425 | 4870 | 0.9086 | 0.9012 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 1311 | 4302 | 4961 | 0.8671 | 0.8567 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 1311 | 4401 | 4973 | 0.8848 | 0.8767 |
MDA-MB-231 | Afatinib | 0.12 | uM | LJP6 | 1 | G23 | 72 | hr | 1311 | 4298 | 4870 | 0.8825 | 0.8722 |
MDA-MB-231 | Afatinib | 0.12 | uM | LJP6 | 2 | G23 | 72 | hr | 1311 | 4336 | 4961 | 0.8739 | 0.8644 |
MDA-MB-231 | Afatinib | 0.12 | uM | LJP6 | 3 | G23 | 72 | hr | 1311 | 4473 | 4973 | 0.8993 | 0.8926 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 1 | G22 | 72 | hr | 1311 | 3458 | 4870 | 0.7100 | 0.6690 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 2 | G22 | 72 | hr | 1311 | 3817 | 4961 | 0.7693 | 0.7446 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 3 | G22 | 72 | hr | 1311 | 3699 | 4973 | 0.7437 | 0.7146 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 1 | G21 | 72 | hr | 1311 | 3413 | 4870 | 0.7008 | 0.6575 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 1311 | 3423 | 4961 | 0.6899 | 0.6483 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 1311 | 3493 | 4973 | 0.7023 | 0.6642 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 1 | G20 | 72 | hr | 1311 | 2884 | 4870 | 0.5922 | 0.5163 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 2 | G20 | 72 | hr | 1311 | 2836 | 4961 | 0.5716 | 0.4944 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 3 | G20 | 72 | hr | 1311 | 2715 | 4973 | 0.5459 | 0.4598 |
MDA-MB-231 | Afatinib | 10 | uM | LJP6 | 1 | G19 | 72 | hr | 1311 | 849 | 4870 | 0.1743 | -0.2054 |
MDA-MB-231 | Afatinib | 10 | uM | LJP6 | 2 | G19 | 72 | hr | 1311 | 826 | 4961 | 0.1665 | -0.2141 |
MDA-MB-231 | Afatinib | 10 | uM | LJP6 | 3 | G19 | 72 | hr | 1311 | 751 | 4973 | 0.1510 | -0.2518 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 1 | H24 | 72 | hr | 1311 | 4260 | 4870 | 0.8747 | 0.8634 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 2 | H24 | 72 | hr | 1311 | 4095 | 4961 | 0.8253 | 0.8096 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 3 | H24 | 72 | hr | 1311 | 4317 | 4973 | 0.8680 | 0.8580 |